Research & Development

干干姐姐妹妹干香港摩天大楼亮灯 呈现“珍惜香港以心建家”


  “我听說,家里的僕婦中間有跟你攀親的?”   听雲瑯這樣說,曹襄不驚慌了,坐在床邊瞅著雲瑯道︰“你知道是不是?”干   阿嬌笑道︰“陛下喝了你們釀造的葡萄釀,還說好,既然手藝不錯,那就不忙著出去,把葡萄宮里的葡萄全釀造成酒再出去不遲。”干姐姐   劉徹抓過白菜掂量一下就交給了身後的隋越,這東西算是雲氏的貢品,不可等閑視之。   奴隸與勛貴之間的戰爭終于出現了。妹妹干

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo